Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2015-10-08 Share Issue/Capital Cha…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 98% confidence The document title is "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and voting rights as of a specific date (September 30, 2015). This content directly relates to the structure of the share capital and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it is a mandatory periodic disclosure regarding the capital base. Although it is a monthly update, it is a direct report on capital structure, not just an announcement of a change or a general regulatory filing.
2015-10-08 French
Share buybacks / Liquidity contracts Description of share buyback program
Transaction in Own Shares Classification · 99% confidence The document explicitly details 'Disclosure of transactions in own shares' over a specific period (28/09/2015 and 02/10/2015), showing the number of shares purchased and the average price. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is not a general announcement of a report (RPA) but the report content itself.
2015-10-05 English
Rachat d'actions / Contrat de liquidité Descriptif du programme de rachat
Transaction in Own Shares Classification · 100% confidence The document is titled "Déclaration des transactions sur actions propres réalisées du 28/09/2015 au 02/10/2015" (Declaration of transactions on own shares carried out from 09/28/2015 to 10/02/2015). It contains a table detailing the purchase ('ACHAT') of 20,000 shares over five days, including quantities, weighted average prices, and total amounts. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). Therefore, the correct filing type code is POS.
2015-10-05 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 98% confidence The document announces the appointment of Stéphane Bessette as Executive Vice President in charge of Human Resources, effective immediately. This type of announcement concerns a change in senior management personnel. Based on the provided definitions, the category 'Board/Management Information' (Code: MANG) is the most appropriate classification for reporting changes in senior management.
2015-10-01 French
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 99% confidence The document is a press release dated October 1st, 2015, announcing the appointment of Stéphane Bessette as Executive Vice President, Human Resources. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The content focuses entirely on personnel changes and includes quotes from management regarding the appointment. This aligns perfectly with the 'Board/Management Information' category (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2015-10-01 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Ipsen dated October 1, 2015, announcing the release of a new batch of the drug Increlex® in the US, following regulatory agreement with the FDA. It provides background on the drug, details the previous supply interruption, and includes standard corporate boilerplate information (About Ipsen, forward-looking statements, contact details). This type of announcement, focusing on a specific operational or product update (drug availability) rather than comprehensive financial results (10-K, IR, ER) or management changes (MANG), is best classified as a general Regulatory Filing or Announcement. Since it is a specific, non-financial operational update that doesn't fit the other specific categories (like DIV, CAP, LTR), the most appropriate fallback is Regulatory Filings (RNS). It is not an Earnings Release (ER) as it contains no financial performance metrics, nor is it a Call Transcript (CT) or Investor Presentation (IP).
2015-10-01 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.